title: Severe angioedema associated with olmesartan.
authors.forename: Jorge Levano
authors.initials: JL
authors.lastname: Vasquez
authors.forename: Juan Carlos
authors.initials: JC
authors.lastname: Jaramillo
authors.forename: Consuelo
authors.initials: C
authors.lastname: Fernandez
authors.forename: Alicia
authors.initials: A
authors.lastname: Enriquez
authors.forename: Ruth
authors.initials: R
authors.lastname: Mielgo
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000799:Angioedema / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects* / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007093:Imidazoles / Q000009:adverse effects* / Q000627:therapeutic use; D012720:Severity of Illness Index; D013777:Tetrazoles / Q000009:adverse effects* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D047228:Angiotensin II Type 1 Receptor Blockers; D006633:Histamine Antagonists; D007093:Imidazoles; D013777:Tetrazoles; C437965:olmesartan